"St. Luke’s Sacred Heart Campus features advanced inpatient and outpatient services along with specialty services in the Hospital, Medical Office Building and at the Sigal Center for Family Medicine. Patients benefit from emergency room services, surgical services, behavioral health services, radiology & lab services and more."

During the past decade, Sacred Heart Hospital conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 5 clinical trials were completed, i.e. on average, 500% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sacred Heart Hospital" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 3 trials, followed by "NSABP Foundation Inc" with 3 trials sponsored, "National Cancer Institute (NCI)" with 2 trials sponsored, "Johns Hopkins University" with 1 trials sponsored and "Organogenesis" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sacred Heart Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 6 trials as a collaborator, "American College of Surgeons" with 2 trials as a collaborator, "North Central Cancer Treatment Group" with 2 trials as a collaborator, "SWOG Cancer Research Network" with 2 trials as a collaborator and "AstraZeneca" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Sacred Heart Hospital" are "Breast Cancer" (6 trials), "Angina Pectoris" (1 trials), "Breast Adenocarcinoma" (1 trials), "Breast Ductal Carcinoma In Situ" (1 trials) and "Chronic Vascular Ulcer" (1 trials). Many other conditions were trialed in "Sacred Heart Hospital" in a lesser frequency.

Most popular intervention types in "Sacred Heart Hospital" are "Drug" (6 trials), "Other" (5 trials), "Radiation" (5 trials), "Procedure" (3 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (2 trials), "Letrozole" (2 trials), "Radiation Therapy" (2 trials), "axillary lymph node dissection" (2 trials) and "sentinel lymph node biopsy" (2 trials). Other intervention names were less common.

The vast majority of trials in "Sacred Heart Hospital" are 8 trials for "Female" genders and 3 trials for "All" genders.

Currently, there are NaN active trials in "Sacred Heart Hospital". undefined are not yet recruiting, undefined are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Sacred Heart Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Sacred Heart Hospital, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".